BALDO LANCE 4
4 · Adaptive Biotechnologies Corp · Filed Mar 8, 2022
Insider Transaction Report
Form 4
BALDO LANCE
Chief Medical Officer
Transactions
- Sale
Common Stock
2022-03-07$12.01/sh−2,373$28,500→ 20,521 total
Footnotes (1)
- [F1]This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.